Top Page
Althea Group Holdings Ltd.
(Sydney:AGH)
Althea Group Holdings Ltd. (AGH) vs. iShares MSCI Australia ETF (EWA)
Althea Group Holdings Ltd. Business Overview & Revenue Model
Althea Group Holdings Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.04M | 15.49M | 29.40M | 24.82M | 20.08M | 11.07M |
| Gross Profit | 6.32M | 7.47M | 17.46M | 12.62M | 9.29M | 5.29M |
| EBITDA | -2.13M | -2.40M | -23.48M | -10.44M | -9.32M | -13.03M |
| Net Income | -4.94M | -8.35M | -32.06M | -13.72M | -12.12M | -15.05M |
Balance Sheet | ||||||
| Total Assets | 20.49M | 20.49M | 23.65M | 48.34M | 56.56M | 53.91M |
| Cash, Cash Equivalents and Short-Term Investments | 528.00K | 528.00K | 331.00K | 3.87M | 6.21M | 6.39M |
| Total Debt | 5.19M | 5.19M | 6.54M | 4.85M | 5.14M | 4.05M |
| Total Liabilities | 21.06M | 21.06M | 23.34M | 18.57M | 15.12M | 11.22M |
| Stockholders Equity | -574.00K | -574.00K | 314.00K | 29.77M | 41.45M | 42.70M |
Cash Flow | ||||||
| Free Cash Flow | -5.71M | -8.01M | -4.83M | -7.78M | -10.04M | -12.85M |
| Operating Cash Flow | -5.06M | -7.09M | -4.39M | -6.29M | -9.05M | -10.45M |
| Investing Cash Flow | 1.08M | 978.00K | 2.29M | -1.49M | -982.00K | -2.40M |
| Financing Cash Flow | 7.42M | 6.31M | -1.44M | 5.55M | 9.89M | 9.18M |
Althea Group Holdings Ltd. Technical Analysis
Althea Group Holdings Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | ― | ― | ― | ― | -3.82% | 79.24% | |
41 Neutral | AU$19.03M | -1.28 | ― | ― | -47.30% | 82.53% | |
39 Underperform | AU$4.26M | 16.00 | ― | ― | 69.59% | ― | |
38 Underperform | AU$8.24M | ― | -401.36% | ― | -26.49% | 61.72% |
Althea Group Holdings Ltd. Corporate Events
Althea Group Holdings Ltd. announced the cessation of Alan Boyd as a director effective October 6, 2025. Boyd held 170,000 ordinary class shares in the company. This change in the board may impact the company’s strategic direction and governance, potentially affecting stakeholder confidence and the company’s market positioning.
Althea Group Holdings Ltd. has announced the appointment of Manik Pujara as a director, effective October 6, 2025. This strategic addition to the board is expected to enhance the company’s leadership and potentially influence its strategic direction, particularly in the medicinal cannabis market. Mr. Pujara holds a significant interest in the company through Trinetra Holdings Pty Ltd, with 5,600,000 ordinary class shares, indicating a vested interest in the company’s future success.
Althea Group Holdings Ltd has announced the appointment of Mr. Manik Pujara as a Non-Executive Director, succeeding Mr. Alan Boyd who is retiring from the Board. Mr. Pujara, with over 15 years of experience in corporate governance and financial strategy, is expected to provide valuable insights as AGH continues its transformative journey toward growth and operational excellence. The company, which focuses on THC beverage manufacturing, anticipates that Mr. Pujara’s expertise will be instrumental in achieving its strategic growth ambitions.
Althea Group Holdings Ltd. has announced a change in its substantial shareholders, with Joshua Fegan ceasing to be a substantial holder as of October 1, 2025. This change resulted from an on-market sale of 10,600,000 ordinary shares, reducing Fegan’s holding from 5.66% to 4.58%. This transaction may impact the company’s shareholder structure and influence voting dynamics, though the broader implications for stakeholders remain unspecified.
Althea Group Holdings Ltd. has announced the application for quotation of 100 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially benefiting stakeholders by increasing liquidity and visibility in the market.
Althea Group Holdings Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is now available on their website. The statement, approved by the board, outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, including the roles and responsibilities of the board and management, appointment checks for directors, and accountability measures for the company secretary.
Althea Group Holdings Ltd has released its Corporate Governance Statement for the 2025 financial year, emphasizing its adherence to the ASX Corporate Governance Principles and Recommendations. The Board of Directors is committed to guiding the company’s strategic direction, governance, and operations, ensuring effective risk management and compliance frameworks. This announcement underscores the company’s dedication to ethical decision-making and stakeholder interests, which is crucial as it continues to grow in size and complexity.
Althea Group Holdings Limited has released its financial statements for the year ending June 30, 2025. The report includes comprehensive financial data such as profit or loss, financial position, and cash flows, which are crucial for stakeholders to assess the company’s financial health and operational performance.
Althea Group Holdings Ltd. announced the issuance of 22 million unquoted securities in the form of options, set to expire on September 30, 2028. This move is part of previously announced transactions and is not intended for quotation on the ASX, potentially impacting the company’s financial strategy and stakeholder interests.
Althea Group Holdings Ltd. has announced the application for quotation of 13,064,228 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of the company’s strategic efforts to enhance its financial flexibility and strengthen its market position in the medicinal cannabis sector.
Althea Group Holdings Ltd. announced the quotation of 140,690,000 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from September 26, 2025. This move is part of a previously announced transaction and signifies a strategic step in enhancing the company’s capital structure, potentially impacting its market positioning and providing opportunities for stakeholders.
Althea Group Holdings Ltd. has announced the issuance of 2,592,472 fully paid ordinary securities, which are set to be quoted on the ASX. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operations and stakeholders positively.
Althea Group Holdings Ltd. announced a proposed issue of 2,592,572 ordinary fully paid securities, scheduled for September 26, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s market positioning by increasing its capital base and enabling further expansion or development initiatives.
Althea Group Holdings Ltd. is offering up to 100 Cleansing Offer Shares at A$0.10 per share and 22 million New Options. The Cleansing Offer aims to remove trading restrictions on upcoming shares, while the Options Offer ensures compliance with the Corporations Act for the on-sale of New Options and their resulting shares.
Althea Group Holdings Ltd. has announced a proposed issue of securities, including 22 million options and over 141 million fully paid ordinary shares, with an issue date set for September 26, 2025. This move is likely aimed at raising capital to support the company’s operations and strategic initiatives, potentially strengthening its market position in the medicinal cannabis industry.
Althea Group Holdings Ltd. has successfully raised $2.55 million through a share placement to fund growth initiatives and capital projects for its subsidiary, Peak Processing. This strategic move aligns with the company’s focus on the THC beverage market, where Peak holds a significant market share in Canada and is expanding into the US. The funds will support customer development and enhance Peak’s competitive position in the growing THC beverage industry, which is experiencing increased consumer acceptance and regulatory easing.
Althea Group Holdings Limited (ASX: AGH) has requested a trading halt on its securities on the Australian Securities Exchange. This halt is to manage the company’s continuous disclosure obligations in anticipation of an announcement regarding a capital raise. The halt will remain in effect until the earlier of the announcement or the commencement of normal trading on 17 September 2025.
Althea Group Holdings Ltd. reported a significant decrease in revenue and losses for the year ending June 2025, with a 23.1% drop in revenue and a 74% reduction in losses compared to the previous year. The company underwent several strategic changes, including the sale of certain assets and the incorporation of a joint venture in the US, which are expected to impact its future operations and market positioning. Additionally, the company secured funding through placements and loans, and entered into a manufacturing agreement with The Boston Beer Company, indicating a focus on expanding its product offerings and market reach.
Althea Group Holdings Ltd announced that its subsidiary, Althea Company Pty Ltd, has entered into a Deed of Company Arrangement (DOCA) under the administration of Salea Advisory. This arrangement involves a $200,000 loan from AGH to the subsidiary to fund the DOCA process, with the directors of the subsidiary lending the same amount back to AGH. The DOCA is not expected to impact AGH’s operations or its North American THC beverage business, Peak Processing Solutions.
Althea Group Holdings Ltd. announced the issuance of 5,000,000 unquoted options set to expire on August 1, 2027, with an exercise price of $0.03. This move is part of a previously announced transaction and is not intended to be quoted on the ASX, potentially impacting the company’s capital structure and offering strategic flexibility for future growth.
Althea Group Holdings Ltd. has announced the issuance of 13,064,228 performance rights as part of an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, and this move is likely aimed at motivating and retaining key personnel, which could have implications for the company’s operational efficiency and competitive positioning in the market.
Althea Group Holdings Ltd. has announced the issuance of 20,056,731 ordinary fully paid securities on August 1, 2025, as part of previously announced transactions. This development is expected to enhance the company’s market presence by increasing its share liquidity and potentially attracting more investors, thereby strengthening its position in the industry.
Althea Group Holdings Ltd. has announced the issuance of 2,834,855 fully paid ordinary securities on August 1, 2025. This move is part of a previously announced transaction, indicating a strategic step to enhance the company’s market presence and potentially increase its capital base, which could have significant implications for its stakeholders and market positioning.
Althea Group Holdings Ltd. has announced a proposed issue of securities, including 5,000,000 options and 100 fully paid ordinary shares, with a proposed issue date of August 1, 2025. This strategic move is expected to enhance the company’s capital structure, potentially strengthening its market position and providing additional resources to support its growth and operational objectives.
Althea Group Holdings Ltd. has announced a proposed issue of 2,834,855 ordinary fully paid securities, with the issuance date set for August 1, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s market positioning by increasing its capital base and enhancing its ability to invest in growth opportunities.
Althea Group Holdings Ltd. has announced a prospectus offering involving two main components: a Cleansing Offer and an Options Offer. The Cleansing Offer aims to issue up to 100 shares at A$0.10 each to raise a nominal amount of $10, primarily to remove trading restrictions on the sale of shares issued in August 2025. The Options Offer involves issuing 5 million new options to ensure compliance with the Corporations Act, allowing the sale of these options and any shares resulting from their exercise. This strategic move is intended to facilitate trading flexibility and compliance with regulatory requirements, potentially impacting the company’s market operations and investor relations.
Althea Group Holdings Ltd. has released its June 2025 Quarterly Activities & Cashflow Report, detailing its financial and operational performance. The report highlights the company’s activities in Canada and the USA, indicating strategic developments and financial outcomes that could influence its market positioning and stakeholder interests.